PRM trades 9.2% below Wall Street's consensus target of $37.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes PRM achieves its forward estimates and maintains a stable P/E multiple of 19.4x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 7, 2026, Perimeter Solutions, S.A. (PRM) has a Wall Street consensus price target of $37.00, based on estimates from 2 covering analysts. With the stock currently trading at $33.88, this represents a potential upside of +9.2%. The company has a market capitalization of $5.53B.
Analyst price targets range from a low of $34.00 to a high of $40.00, representing a 16% spread in expectations. The median target of $37.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, PRM trades at a trailing P/E of -24.7x and forward P/E of 19.4x. Analysts expect EPS to grow +251.4% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
IOSPInnospec Inc. | $2.0B | $82.41 | $115.00 | +39.5% | Hold | 17.2x | 9 |
ASIXAdvanSix Inc. | $542M | $20.10 | $22.00 | +9.5% | Buy | 14.0x | 6 |
KWRQuaker Chemical Corporation | $2.8B | $159.43 | $176.75 | +10.9% | Buy | 22.7x | 14 |
BCPCBalchem Corporation | $5.3B | $167.01 | $175.50 | +5.1% | Buy | 31.9x | 10 |
ALBAlbemarle Corporation | $15.8B | $133.80 | $209.75 | +56.8% | Hold | 10.8x | 45 |
AVNTAvient Corporation | $3.6B | $38.89 | $46.71 | +20.1% | Buy | 12.6x | 20 |
FULH.B. Fuller Company | $3.1B | $58.39 | $69.67 | +19.3% | Buy | 12.0x | 15 |
CBTCabot Corporation | $4.6B | $87.60 | $89.75 | +2.5% | Buy | 13.9x | 15 |
TROXTronox Holdings plc | $962M | $6.03 | $8.33 | +38.1% | Buy | — | 17 |
PRLBProto Labs, Inc. | $1.8B | $77.14 | $38.50 | -50.1% | Hold | 38.2x | 17 |
Quick answers to the most common questions about buying PRM stock.
The consensus price target for PRM is $37, close to the current price of $33.88 (9.2% implied move). Based on 2 analyst estimates, the stock appears fairly valued near current levels.
PRM has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $37 implies 9.2% upside from current levels.
With a forward P/E of 19.4266x, PRM trades at a relatively low valuation. The consensus target of $37 implies 9.2% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $40 for PRM, while the most conservative target is $34. The consensus of $37 represents the median expectation. These targets typically reflect 12-month expectations.
PRM is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month PRM stock forecast based on 2 Wall Street analysts shows a consensus price target of $37, with estimates ranging from $34 (bear case) to $40 (bull case). The median consensus rating is "Buy".
PRM trades at a forward P/E ratio of 19.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
PRM appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $37 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
PRM analyst price targets range from $34 to $40, a 16% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $37 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.